Navigation Links
Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival

and thrombocytopenia (each 3%).

For more information about VELCADE clinical trials, patients and physicians can contact the Millennium Medical Product Information Department at 1-866-VELCADE (1-866-835-2233).

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. Millennium's website is www.millennium.com.

This press release contains "forward-looking statements," including statements about the Company's growth and development of products. Various important risks may cause the Company's actual results to differ materially from the results indicated by these forward-looking statements, including: adverse results in its drug discovery and clinical development programs; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; the Company's dependence upon strategic alliance partners to develop and commercialize products and services based on its work; difficulties or delays in obtaining regulatory approvals to market products and services resulting from its development efforts; product withdrawals; competitive factors; difficulties or delays in manufacturing the Company's products; government and third-party reimbursement rates; the commercial success of VELCADE and INTEGRILIN(R) (eptifibatide) Injection; achieving revenue consistent with internal forecasts; and the requirement for substantial funding to c
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
2. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
3. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting

Post Your Comments:
(Date:11/25/2009)...A, Calif., Nov. 25 AMPAC Fine Chem...Corporation (Nasdaq: APFC ) announced today that ...ustainability Award at the Annual Statewide Enviro...cturers and Technology Association (CMTA), the Ind...emical Industry Council of California (CICC) held ...
(Date:11/25/2009)...lif., Nov. 25 Abaxis, In...nufacturing point-of-care blood analysis systems, ...chief executive officer, will present at the 21st ...nesday, December 2, 2009 at 2:00 p.m. ET. The conf...n New York City. ,, About Abaxis ,, Abaxi...
(Date:11/25/2009)...K, Nov. 25 Reportlinker.com announ... in its catalogue: ,, Pain Management - Globa...4220/Pain-Management---Global-Trends.html ,, W... of pain management clinics, and the advent of new...pain management market. Healthcare reforms and rei...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Insulet Corporation to Report Second Quarter 2009 Financial Results on Tuesday August 4 2009 52157 1Insulet Corporation to Report Second Quarter 2009 Financial Results on Tuesday August 4 2009 52157 2More Americans Have Cell Phones Than Dental Coverage 52153 1More Americans Have Cell Phones Than Dental Coverage 52153 2Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results 13099 1Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results 13099 2Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results 13099 3Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results 13099 4Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results 13099 5Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results 13099 6Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results 13099 7
...t Laboratories, Inc.,(NYSE: FRX ) today announced...-controlled clinical trial, published in the Novem...sion, which demonstrated that nebivolol,significan...ressure used as,monotherapy among African-American...also found that nebivolol was well tolerated in co...
...or Africa, Inc. (Other,OTC: RXAF.PK), announced to... trade under the symbol RXAF.PK and that the name ...ill no longer be used as part of,the company,s ope...pany in a reverse merger,completed in May 2007 wit...,its wholly owned subsidiary, Rx Africa (Ethiopia)...
Other Medicine Technology:UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension 2UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension 3Rx for Africa, Inc. Now Trading Under New Symbol (RXAF.PK) 2
(Date:11/27/2009)... , SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCal...nounced that Blair Lambert, CFO/COO, will present ...l be held at the May Fair Hotel in London, England...T. ,, To listen to a live broadcast of The Gymb... please log on to www.gymboree.com, click on "Our ...
(Date:11/27/2009)...ing and cycling plus low-emission vehicles may red... , FRIDAY, Nov. 27 (HealthDay News) -- Encoura...using cars would offer much greater public health ...les, U.K. researchers have found. , The study c...ternative urban land transport scenarios for Londo...
(Date:11/27/2009)... Specialist manufacturers who...ucts are saving millions of dollars by bringing in...ocess. Increasing numbers of pro-active medical ma...ts at the concept stage of their projects, ensurin...g design processes or potentially outdated technol...
(Date:11/26/2009)...e copper sequestering drug tetrathiomolybdate (TM)...treatment of Wilson disease, a disease caused by a...rs. That much is known. Very little, however, is k...el. , A new study led by Northwestern University...the three-dimensional structure of TM bound to cop...
(Date:11/26/2009)... Research Triangle Dental (RT...l North Carolina, today announced the expansion of...LUMINEER Dentist, Dr. Doug Macmillan. , ...riangle Dental is pleased to announce that Dr. Dou...ecently completed an additional advanced training ...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...American Veterinary,Medical Association (AVMA) dec...ons included in the Farm Bill, applauding Congress...mentation of unresolved initiatives., Reaching fi...h that ranges from food safety protection and biot...
...Dynatronics,Corporation (Nasdaq: DYNT ) today ann...March 31, 2008., Sales for the quarter increased ...n the prior year period. For the nine months ended...o the,acquisition of six of the company,s top inde...
...avy consumption tied to arterial stiffening, enlar...y News) -- While research suggests that moderate a... drinking increases blood pressure, stiffens blood...Men who drink more than 21 units of alcohol per we...
...d to beat the sick note culture that sees millions...urvey of smaller business owners. , The UK Busine...sity of Nottingham Institute for Enterprise and In...to the latest UK Business Barometer (UKBB) felt it...
...tion and Hope, WASHINGTON, May 14 The American R... Henry P. Davison Award at the,organization,s Heri...of,Service Dinner is a celebration to recognize th...on each year. Telemundo is,being recognized for it...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSK...hat scientists from the University of Pennsylvania... Health have published the results of,the Company,...he data was published online in the journal Biolog...
Other Medicine News:Health News:AVMA Declares Preliminary Victory on Farm Bill Provisions 2Health News:Dynatronics' Acquisitions Boost Sales 80 Percent in Third Quarter 2Health News:Dynatronics' Acquisitions Boost Sales 80 Percent in Third Quarter 3Health News:Dynatronics' Acquisitions Boost Sales 80 Percent in Third Quarter 4Health News:Excess Drinking Boosts Cardiovascular Disease Risk 2Health News:Taking on Britain's 'sick note culture' 2Health News:American Red Cross Honors Telemundo at Heritage of Service Dinner 2Health News:American Red Cross Honors Telemundo at Heritage of Service Dinner 3Health News:Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals 2Health News:Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals 3Health News:Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals 4
200 L Pipette Tip
StrataTips Pipet Tips, Flat (1-200 l)
MBP Ultra Micro
10 L Low Rentention Pipette Tip
Medicine Products: